(Q71843765)

English

Results of a phase II trial of external beam radiation with etanidazole (SR 2508) for the treatment of locally advanced prostate cancer (RTOG Protocol 90-20)

scientific article published on 01 October 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8948352%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Results of a phase II trial of external beam radiation with etanidazole (SR 2508) for the treatment of locally advanced prostate cancer (RTOG Protocol 90-20) (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8948352%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

phase II clinical trial

1 reference

based on heuristic

inferred from title

author name string

C A Lawton

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8948352%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

C N Coleman

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8948352%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

J W Buzydlowski

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8948352%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

J D Forman

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8948352%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

V A Marcial

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8948352%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

J D DelRowe

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8948352%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

M Rotman

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8948352%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

language of work or name

0 references

publication date

1 October 1996

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8948352%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8948352%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

36

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8948352%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8948352%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

673-680

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8948352%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Cancer statistics, 1993

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900336-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiosensitization of hypoxic cells in vivo by SR 2508 at low radiation doses: A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900336-7

7 January 2021

based on heuristic

inferred from DOI database lookup

SR-2508: a 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical use

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900336-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiologic evidence regarding predisposing factors to prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900336-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypoxic Sensitizers — Implications for Radiation Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900336-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The efficacy of pharmacokinetic monitoring and dose modification of etanidazole on the incidence of neurotoxicity: Results from a phase II trial of etanidazole and radiation therapy in locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900336-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Initial report of the phase I trial of the hypoxic cell radiosensitizer SR-2508

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900336-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I trial of the hypoxic cell radiosensitizer SR-2508: the results of the five to six week drug schedule

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900336-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Is tumour radiosensitization by misonidazole a general phenomenon?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900336-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemical sensitizers for hypoxic cells: a decade of experience in clinical radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900336-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Late results of a trial of hyperbaric oxygen and radiotherapy in head and neck cancer: a rationale for hypoxic cell sensitizers?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900336-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900336-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate Specific Antigen after Irradiation for Prostatic Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900336-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The multi-dose clinical tolerance and pharmacokinetics of the combined radiosensitizers, Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900336-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: report from the DAHANCA 2 study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900336-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Final report on the united states phase i clinical trial of the hypoxic cell radiosensitizer, misonidazole (RO-07-0582; NSC #261037)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900336-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen as a predictor of radiotherapy response and patterns of failure in localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900336-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxygen in human tumors: correlations between methods of measurement and response to therapy. Summary of a workshop held November 19-20, 1992, at the National Cancer Institute, Bethesda, Maryland.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900336-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase 1 study of high-dose metronidazole: a specific in vivo and in vitro radiosensitizer of hypoxic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900336-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Binding of 3H-misonidazole to solid human tumors as a measure of tumor hypoxia.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900336-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen and external beam radiation therapy in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900336-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900336-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0360-3016(96)00336-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8948352%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8948352%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q71843765&oldid=1942465494"